NCT03338907View on ClinicalTrials.gov

CO2 (Carbon Dioxide) - Cerebral Oxygenation

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 25, 2018

Primary Completion Date

October 26, 2018

Study Completion Date

February 12, 2019

Conditions
Hypoxia, Brain
Interventions
DRUG

Oxycarbon (5% CO2+ 95% O2)

Oxycarbon will be administered by mechanical ventilation

Trial Locations (1)

Unknown

University Hospital Zurich, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER

NCT03338907 - CO2 (Carbon Dioxide) - Cerebral Oxygenation | Biotech Hunter | Biotech Hunter